The European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.

3 天之前 · Formerly known as European Journal of Cancer and Clinical Oncology;. 2025 — Volumes 214-220. Volume 220 In progress (2 May 2025)

Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab

The European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.

4 天之前 · The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention.

2023年1月14日 · (ejc)整合了癌症的临床前、数字化、转化和临床研究，从流行病学、癌变和生物学到癌症治疗和病人护理的创新。 该杂志发表原创研究、评论、预览、编辑评论和通信。

2022年12月26日 · EJC整合了癌症的临床前、数字、转化和临床研究，从流行病学、致癌机制和生物学到癌症治疗和病人护理的创新，该杂志发表原始研究、评论、预览、编辑评论和通信。 EJC是欧洲癌症研究和治疗组织（EORTC）和欧洲乳腺癌专家协会（EUSOMA）的官方期刊。 08 投稿须知. 1 Original research articles. 原创研究文章的字数限制为 2500字，参考文献不超过40条。 要求作者提供一个不超过250字的结构化摘要和一个关键词列表。 2 Current Perspectives. 当前 …

The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention.

《欧洲癌症杂志》 (European Journal Of Cancer)是一本以肿瘤学-医学综合研究为特色的国际期刊。 该刊由Elsevier Ltd出版商创刊于1990年，刊期Semimonthly。 该刊已被国际重要权威数据库SCIE收录。 期刊聚焦肿瘤学-医学领域的重点研究和前沿进展，及时刊载和报道该领域的研究成果，致力于成为该领域同行进行快速学术交流的信息窗口与平台。 该刊2023年影响因子为7.6。 CiteScore指数值为11.5。

审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！